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Abstract: Shigella is a highly infectious human pathogen responsible for 269 million infections and
200,000 deaths per year. Shigella virulence is absolutely reliant on the injection of effector proteins
into the host cell cytoplasm via its type three secretion system (T3SS). The protein Spa47 is a T3SS
ATPase whose activity is essential for the proper function of the Shigella T3SS needle-like apparatus
through which effectors are secreted. A phosphoproteomics study recently found several Shigella T3SS
proteins, including Spa47, to be tyrosine phosphorylated, suggesting a means of regulating Spa47
enzymatic activity, T3SS function, and overall Shigella virulence. The work presented here employs
phosphomimetic mutations in Spa47 to probe the effects of phosphorylation at these targeted tyrosines
through in vitro radiometric ATPase assays and circular dichroism as well as in vivo characterization
of T3SS secretion activity, erythrocyte hemolysis, and cellular invasion. Results presented here
demonstrate a direct correlation between Spa47 tyrosine phosphorylation state, Spa47 ATPase activity,
T3SS function, and Shigella virulence. Together, these findings provide a strong foundation that
leads the way to uncovering the specific pathway(s) that Shigella employ to mitigate wasteful ATP
hydrolysis and effector protein secretion when not required as well as T3SS activation in preparation
for host infection and immune evasion.
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1. Introduction
Shigella are Gram-negative, rod-shaped, facultative anaerobic bacteria that are closely
related to Escherichia coli and belong to the large family Enterobacteriaceae. Each of the four
species of Shigella are human pathogens that are most commonly spread through the fecal–
oral route and contaminated water supplies [1]. Exposure to as few as 10–100 organisms
supports the onset of a full shigellosis infection resulting in a severe and potentially
deadly form of bacillary dysentery [2]. In fact, Shigella is responsible for an estimated
269 million infections worldwide and as many as 200,000 deaths annually [3]. While
shigellosis infections disproportionately burden developing regions of the world where
there is limited access to clean drinking water and antibiotic treatment, there is also an
urgent concern surrounding the rapid emergence of antibiotic-resistant Shigella strains
in both developing and industrialized nations throughout the world [4,5]. These recent
developments underscore the need to better understand the mechanism(s) that Shigella
uses to infect human hosts and identify potential targets for the formulation of efficient
non-antibiotic countermeasures against shigellosis.
Like many Gram-negative pathogenic bacteria, Shigella rely absolutely on a type
three secretion system (T3SS) for virulence [6–9]. The Shigella T3SS injects bacterial effector
proteins directly into the cytoplasm of eukaryotic host cells, subverting a milieu of host
cell functions and allowing the bacteria to invade the cells of the colonic epithelium, evade
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host immune defenses, and spread throughout the infected tissues [10,11]. Structurally,
the T3SS injectisome responsible for these processes resembles a hypodermic syringe and
needle comprised of several distinct regions that are highly structurally conserved among
the pathogens that utilize them [12–14]. The cytoplasmic bulb of the injectisome resides
within the cytoplasm of the bacteria and is often referred to as the sorting platform as
recent structural and biochemical studies have shown that it contains multiple copies
of a T3SS ATPase necessary for the proper function of the system, regulatory proteins
capable of enhancing and inhibiting activity of the ATPase, and T3SS chaperone binding
proteins that presumably guide protein secretion through the apparatus by recognizing
and removing T3SS chaperones from secreted translocator proteins [15–18]. The basal
body of the apparatus interacts with the cytoplasmic bulb and provides an anchor for
the apparatus that spans the inner and outer membranes of the bacteria. This region has
been suggested to contain protein complexes that provide dedicated channels that utilize
the potential energy of proton and other ion-derived electrochemical gradients across the
inner membrane to support protein secretion through the apparatus [19–21]. The hallmark
needle-like structure itself is a homo-oligomeric complex that extends approximately 45 Å–
80 Å from the basal body and terminates slightly beyond the associated lipopolysaccharide
layer, providing a ~2.5 Å (inner diameter) unidirectional conduit that guides the secretion
of T3SS effectors from the bacterial cytoplasm [22,23]. Finally, the distal tip of the needle is
terminated with a multi-protein tip complex that acts as an environmental sensor, prevents
premature protein secretion through the apparatus, and inserts a translocon pore in the
eukaryotic host cell membrane, providing direct access for T3SS protein secretion into the
host cell cytoplasm [24–29].
The clear correlation between T3SS activity and Shigella virulence has fueled a number
of studies defining the regulatory means that Shigella utilize to prevent wasteful expression and secretion of T3SS proteins prior to encountering a host’s colonic epithelial cells.
These regulatory mechanisms include the temperature-dependent transcriptional regulation of critical T3SS components and both bile salt and lipid sensation by proteins within
the tip complex that trigger subsequent steps in protein secretion and apparatus maturation [25,26,30–33]. More recently, a pioneering tyrosine phosphoproteomics study in
Shigella found that approximately 15% of Shigella proteins contained one or more posttranslational tyrosine phosphorylation modifications [34]. While the Shigella T3SS ATPase,
Spa47, represents only one of the ≥573 proteins identified with phosphotyrosine modifications in the proteome, Spa47’s recently described role(s) in supporting T3SS injectisome
formation, protein secretion, and overall pathogen virulence suggest that posttranslational
phosphorylation may serve as a novel and potent means for regulating T3SS activity and
Shigella virulence [35,36], leading to the question of whether these modifications are an
integral part of an intricate regulatory process.
Here, we utilize a series of phosphomimetic substitutions at two tyrosine residues
identified as targets for in vivo phosphorylation. In vitro biophysical characterization of
the purified mutants together with enzyme kinetic analyses of both isolated monomeric
and oligomeric Spa47 mutant species provide insight into the importance of each tyrosine
in Spa47 structure, stability, and enzymatic function and inform on the potential impact
of the posttranslational phosphorylation of each. Subsequent in vivo characterization of
Shigella strains expressing each of the engineered Spa47 mutants further uncover a strong
virulence dependence on mutations to the highly conserved Spa47Y274 target. Together, the
findings presented here clearly demonstrate the importance of the identified Spa47 tyrosine
residues in both Spa47 function and Shigella virulence, providing a strong foundation for
follow-up studies uncovering the specific regulatory pathway(s) responsible for Spa47
regulation as well as identifying a priority target for the development of much needed
non-antibiotic T3SS ATPase inhibitors.
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2. Results
2.1. Structural Insights into the Roles of Post-Translationally Targeted Tyrosines in Spa47
To better understand the potential effects of phosphorylating tyrosines 274 and 398,
a homo-hexameric Spa47 model was generated as described previously [35]. Briefly, the
recently solved 2.15 Å structure of Spa47K165A (PDB ID 5SYP) was aligned to each of the
protomers of the 2.8 Å hetero-hexameric F1 α3 β3 ATP synthase structure (PDB ID 1BMF)
using PyMOL. The location of the tyrosine residues with respect to the interfacial nucleotide
binding site was considered to determine whether phosphorylation would likely lead to
direct effects within the active site of Spa47. As seen in Figure 1, the tyrosine residues
are unlikely to participate directly in catalysis as they are located on opposite poles of the
complex, nearly 50 Å from one another, and each is greater than 20 Å from the active site that
is positioned within a protomer interface approximately midway between the highlighted
tyrosines. Specifically, tyrosine 274 is located on a long loop connecting helices α6 and
α7 (Figure 1A). From its position on this loop at the protomer interface, tyrosine 274 can
potentially interact with residues displayed on helices α5 and α6 of the adjacent protomer,
likely including hydrophobic interactions between the phenyl ring of Y274 and the aliphatic
sidechains of V221 and/or V261 (Figure 1A). Tyrosine 398, on the other hand, is located
on the opposite pole of the Spa47 structure relative to Y274. A 180◦ rotation of the Sp47
model shows that Y398 is also located at a protomer interface within the homo-hexameric
model but is located within helix α12, limiting local flexibility relative to the loop-bound
Y274. Additionally, the model suggests that from this position, Y398 is too far from the
adjacent protomer to support either electrostatic or hydrophobic interaction (Figure 1B).
Previous identification of in vivo phosphorylation at both of these tyrosine residues [34],
together with their putative location at catalytically-critical Spa47 interfaces [37] suggests
that phosphorylation could provide a means for regulating Spa47 activity, T3SS function,
and ultimately Shigella virulence. While Spa47 currently represents the only T3SS ATPase
for which posttranslational phosphorylation has been uncovered, it is tempting to speculate
that such a regulatory mechanism would be conserved among T3SS ATPases from different
pathogens. In fact, a Clustal Omega sequence alignment of Spa47, F1 β, and several related
T3SS ATPases identifies a near perfect conservation of Y274 with the only non-identical
residue in the alignment being a phenylalanine in EscN from E. coli, providing anecdotal
support for the importance of Y274 in T3SS ATPase function and its potential as a regulatory
target (Figure 1C). Evaluation of the equivalent positions to Y398 in the isozymes, on the
other hand, shows a stark lack of conservation, with none of the other aligned ATPase
sequences containing a tyrosine (or any other residue capable of being phosphorylated) at
this position, suggesting that it is not involved in a conserved mechanistic or regulatory
role, though not necessarily ruling out its importance in the Shigella T3SS.
2.2. Phosphomimetic Tyrosine Mutations Impact Spa47 ATPase Activity
We have previously shown that stable Spa47 oligomers display significantly enhanced
ATPase activity compared to isolated monomeric Spa47 as oligomerization supports critical
active site contributions from adjacent protomers [35,36]. Furthermore, disruption of
interfacial salt bridges along the protomer interface was shown to be detrimental to catalytic
activity in vitro and T3SS function in vivo, supporting the idea that disrupting interactions
with even a single residue can reduce/eliminate Spa47 activity [37]. The potential effects of
phosphorylating Y274 and Y398 on Spa47 ATPase activity were tested by independently
mutating each of them to the commonly utilized tyrosine phosphomimetic glutamate as it
introduces a negative charge in the “R” group and provides similar electrostatic properties
as a phosphorylated tyrosine [38,39]. The native tyrosine residues were additionally
mutated to phenylalanine as this mutation maintains the aromatic “R” group via the
phenyl ring while eliminating the alcohol functional group required as a nucleophile that
allows posttranslational phosphorylation. Finally, tyrosine to alanine mutations were
engineered to eliminate the “bulk” of the native sidechain, the ability to participate in
intermolecular salt bridges, and the ability to become phosphorylated. The effect of each
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of the engineered Spa47 point mutations on ATPase activity was determined for isolated
monomeric and oligomeric Spa47 using a radiometric α-32 P-ATP multiple time point
activity assay (Figure 2). The in vitro activity results show that the full-length wild-type
monomeric and oligomeric Spa47 species behaved as previously reported, hydrolyzing ATP
at rates of 0.33 ± 0.02 (µmol ADP/min)/mg Spa47 and 1.35 ± 0.07 (µmol ADP/min)/mg
Spa47, respectively [40]. Mutations to Y274 show a clear pattern in which the extent
of reduction in ATPase activity of both the monomeric and oligomeric species increases
moving from the native tyrosine to phenylalanine, to alanine, and to glutamate, with
the phosphomimetic glutamate mutation resulting in complete elimination of activity
(0.00 ± 0.01 µmol ADP/min)/mg Spa47 and 0.01 ± 0.01 µmolADP/min)/mg Spa47
Pathogens 2022, 11, x FOR PEER REVIEW
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We have previously shown that stable Spa47 oligomers display significantly enhanced ATPase activity compared to isolated monomeric Spa47 as oligomerization supports critical active site contributions from adjacent protomers [35,36]. Furthermore, disruption of interfacial salt bridges along the protomer interface was shown to be detrimental to catalytic activity in vitro and T3SS function in vivo, supporting the idea that
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The Y398E mutant exhibited similar effects with the monomeric and oligomeric fracThe Y398E mutant exhibited similar effects with the monomeric and oligomeric fractions, hydrolyzing ATP at negligible rates of 0.05 ± 0.01 (μmol ADP/min)/mg Spa47 and
tions, hydrolyzing ATP at negligible rates of 0.05 ± 0.01 (µmol ADP/min)/mg Spa47 and
−0.02 ± 0.03 (μmol ADP/min)/mg Spa47, supporting the idea that phosphorylation of ei−0.02 ± 0.03 (µmol ADP/min)/mg Spa47, supporting the idea that phosphorylation of
ther tested tyrosine would inhibit Spa47 activity. Interestingly, however, the engineered
either tested tyrosine would inhibit Spa47 activity. Interestingly, however, the engineered
Y398F and Y398A mutants displayed equivalent and modest reductions in Spa47 activity,
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alanine methyl group in this position.
The observed effects on Spa47 activity resulting from independently mutating Y274
The observed effects on Spa47 activity resulting from independently mutating Y274
and Y398 led us to consider the possibility that tyrosine 274 and tyrosine 398 may both be
and Y398 led us to consider the possibility that tyrosine 274 and tyrosine 398 may both
phosphorylated
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guided the identification of these tyrosines as targets was not sensitive to this possibility as
the two sites are located 124 residues apart and the proteolytic digestion employed prior to
mass spectrometry analysis prevented detection of the dual-phosphorylated product in
question [34]. We attempted to address this possibility by engineering a Spa47Y274E/Y398E
double mutant with both tyrosines mutated to phosphomimetic glutamates. Despite
significant efforts, however, recombinant expression of the double mutant resulted in
insoluble inclusion bodies of the engineered Spa47Y274E/Y398E product. While this does not
necessarily rule out the possibility of Spa47 phosphorylation at multiple sites, it prevented
us from further examining the Spa47Y274E/Y398E mutant in this study and suggests that
either of the singly phosphorylated products is more stable and a more likely means of
T3SS regulation in vivo.
2.3. Phosphomimetic Tyrosine Mutations Impact Spa47 Thermal Stability
Far-UV circular dichroism (CD) was employed to determine whether the engineered
mutations result in perturbations to the overall protein secondary structure and/or overall
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structural stability of Spa47. Far-UV circular dichroism spectra and thermal unfolding
profiles were collected and evaluated for both monomeric and oligomeric isolates of the
Spa47 tyrosine mutants (Supplementary Figure S1). CD data were not collected for the
Spa47Y398E oligomer species as limited stability/solubility at concentrations required for
CD analysis prevented its characterization. Each of the collected spectra are characteristic of
proteins containing significant alpha helical character (consistent with previously published
CD spectra and crystal structures of Spa47) [35] and none are indicative of proteins with
significantly compromised secondary structures. In addition to similar spectral characteristics, the observed wild-type Spa47 melt temperatures of 44.4 ± 0.2 ◦ C and 43.5 ± 1.5 ◦ C
for the monomeric and oligomeric species, respectively, are in good agreement with those
determined previously (Table 1) [16]. The mutations generally had little effect on the
melt temperatures of the isolated oligomers, with only the Y398A mutant displaying a
significantly altered Tm (40.5 ± 1.9 ◦ C). The thermal stability of the monomeric species,
however, appears to be more sensitive to the mutations than the isolated oligomers. In
fact, with the exception of the Y398F mutant, each exhibited significantly decreased melt
temperatures compared to WT Spa47. The Y398E mutation resulted in the largest decrease
in stability with a Tm of only 36.0 ± 0.6 ◦ C, with similar, but perhaps enhanced, effects on
the mutant’s structural stability likely preventing characterization of the corresponding
mutant oligomeric species.
Table 1. Secondary Structure Thermal Stability of Engineered Spa47 Tyrosine Mutants.

Spa47
Wild-Type Spa47
Spa47Y274F
Spa47Y274A
Spa47Y274E
Spa47Y398F
Spa47Y398A
Spa47Y398E

Melt Temperature (Tm) a
(◦ C ± S.D.)
Monomer

Oligomer

44.4 ± 0.2
42.1 ± 0.5 *
39.5 ± 0.4 *
40.1 ± 0.2 *
43.9 ± 0.5 *
41.3 ± 0.2 *
36.0 ± 0.6 *

43.5 ± 1.5
41.6 ± 0.1
41.8 ± 1.4
45.1 ± 0.5
44.1 ± 1.7
40.5 ± 1.9 *
N/A

a

Secondary structure thermal stability of engineered Spa47 mutants was quantified by monitoring the CD signal
at 222 nm as the sample temperature was increased from 10 ◦ C to 90 ◦ C. All results are reported as the mean
Tm ± S.D. from three independent analyses spanning two separate protein preparations. (*) Indicates statistical
significance compared to the appropriate oligomer state of wild-type Spa47 protein (one-way ANOVA followed
by a Dunnett’s post hoc test, p ≤ 0.05).

2.4. Phosphomimetic Substitutions to Spa47Y274 , but Not Spa47Y398 , Regulate Protein Secretion
through the T3SS Injectisome
Spa47-catalyzed ATP hydrolysis is essential for protein secretion through the T3SS
needle-like injectisome and is directly associated with Shigella virulence. To determine
the effect that the tested phosphomimetic Spa47 mutations had on the ability of Shigella
to actively secrete effector proteins through the injectisome, levels of the secreted Shigella
translocator protein IpaC were quantified following the Congo Red activation of Shigella
strains expressing each of the engineered Spa47 tyrosine mutants (Figure 3). While none of
the tested mutations targeting the non-conserved Y398 resulted in a change in secretion
levels of the translocator protein IpaC, mutations to the highly conserved Y274 produced
a distinct pattern in which the secretion levels decrease moving from the native tyrosine
to the most conserved mutation of phenylalanine, to alanine, and finally to the phosphotyrosine mimic glutamate. The Spa47Y274E mutant reduced IpaC secretion by 77 ± 9%,
suggesting that this mutation not only eliminates Spa47 catalysis in vitro (Figure 2), but also
significantly inhibits T3SS function in vivo. Previous work identifying posttranslational
phosphorylation of Y274 in vivo [34], together with these findings, strongly suggest that
posttranslational phosphorylation of Y274 could influence T3SS activity and provide a
non-transcriptionally derived means for regulating T3SS activity in vivo.
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2.5. Spa47Y274 , but Not Spa47Y398 , Is Critical to Shigella Virulence Phenotype

Secretion of the translocator protein IpaC through the injectisome and its incorporation
into the translocon pore in the host cell membrane marks the final step in the maturation of
the type three secretion apparatus and ultimately allows the secretion of effector proteins
into the eukaryotic host cell cytoplasm [15,25]. Secretion of T3SS effectors into the host
cytoplasm then supports invasion of the host cell, escape from the resulting vacuole,
and evasion of host immune responses [6–11]. Shigella strains expressing the engineered
Spa47 phosphomimetics resulted in significantly different effects on IpaC secretion levels,
specifically suggesting that phosphorylation of Spa47Y274 inhibits protein secretion while
phosphorylation of Y398 does not (Figure 3). To better understand the consequences that
Spa47 phosphorylation has on T3SS-mediated Shigella virulence, Shigella strains expressing
the engineered phosphomimetic Spa47 tyrosine mutants were examined for their ability to
both lyse red blood cells (RBC) and to invade cultured epithelial cells (Table 2). The RBC
hemolysis assay is specifically sensitive to the pathogen’s ability to form the T3SS translocon
pore within a host cell membrane, a critical first step in Shigella’s virulence pathway that is
known to be directly related to secretion of IpaC through the injectisome and be absolutely
dependent on enzymatically-competent Spa47 [24,36,41,42]. The hemolysis results correlate
strongly with the IpaC secretion data also collected in this study (Figures 2 and 3) with the
hemolytic phenotype of the Spa47Y274F strain essentially equivalent to the wild-type Shigella
strain and the Spa47Y274A and phosphomimetic Spa47Y274E strains exhibiting significantly
reduced hemolytic phenotypes at 78 ± 8% and 46 ± 3% of wild-type, respectively. Again,
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consistent with the collected IpaC secretion data, none of the mutants expressing Y398
variants exhibited reduced hemolysis phenotypes, and rather, each resulted in enhanced
hemolytic phenotype, though the origin of this enhancement remains enigmatic.
Table 2. Effect of Engineered Spa47 Phosphomimetic Mutations on Shigella Hemolysis and
Invasion Phenotype.
Relative Phenotype
(% ± S.D.)

Spa47
Spa47 null
Vector Control
Wild-Type Spa47
Spa47Y274F
Spa47Y274A
Spa47Y274E
Spa47Y398F
Spa47Y398A
Spa47Y398E

Hemolysis a

Invasion b

3±0*
3±0*
100 ± 0
96 ± 7
78 ± 8 *
46 ± 3 *
119 ± 3 *
132 ± 6 *
117 ± 8 *

1±1*
0±0*
100 ± 0
99 ± 13
51 ± 9 *
32 ± 11 *
90 ± 10
110 ± 20
119 ± 16

a

Hemolysis results are presented as a percentage of the hemoglobin released from red blood cells by the S. flexneri
strain expressing wild-type Spa47. b Invasion results are presented as a percentage of the number of colonies
resulting from the S. flexneri strain expressing wild-type Spa47. All data are presented as the mean ± S.D.
resulting from three independent experimental data sets spanning two biological replicates. (*) Indicates statistical
significance compared to the wild-type Spa47 strain (one-way ANOVA followed by a Dunnett’s post hoc test,
p ≤ 0.05).

Like RBC hemolysis, the ability of Shigella to invade eukaryotic epithelial cells also
requires the formation of T3SS translocon pores in the host cell membrane, but additionally
requires the active secretion of several effector proteins into the host cell cytoplasm to
subvert critical cellular functions such as actin polymerization and induce macropinocytotic uptake of the bacteria, testing the full range of function of the T3SS with respect to
Shigella’s ability to gain access to host cell cytoplasm. In a similar, but exaggerated trend, the
Shigella strain expressing the conservative Spa47Y274F mutant was not affected with respect
to invasion phenotype, while the strains expressing the Spa47Y274A and phosphomimetic
Spa47Y274E mutants demonstrated significantly reduced invasion phenotypes at 51 ± 9%
and 30 ± 11% of wild type, respectively (Table 2). Again, consistent with the other phenotype studies presented here, however, none of the Spa47Y398 mutants significantly affected
invasion phenotype. Together, these findings demonstrate the importance of the highly
conserved Spa47Y274 residue in supporting overall Shigella virulence with the Spa47Y274E
mutation mimicking the phosphorylation of the native tyrosine resulting in significant
defects in translocator protein secretion through the T3SS injectisome and significantly
reduced hemolytic and invasion phenotypes. Ultimately, these data support the hypothesis
that the posttranslational phosphorylation of Spa47Y274 may serve as a critical native means
of regulating Shigella T3SS activity and virulence as well as identifying a potentially potent
target for non-antibiotic small molecule therapeutics against not only Shigella, but perhaps
the many pathogens that rely on T3SSs as critical virulence factors and share this conserved
tyrosine residue in their T3SS-associated ATPases.
3. Discussion
Some of the first descriptions of bacterial T3SSs (not including flagellar T3SSs) were
those of Pseudomonas and Yersinia in 1993, providing important insight into their virulence
mechanisms [43,44]. Two years later, Sansonetti and colleagues made the important discovery of a single T3SS in Shigella, initiating a new direction of study into the mode of infection
of yet another important human pathogen [45]. Today, more than twenty bacterial species
are known to express T3SSs as critical components in their virulence arsenals [8], and work
continues to dissect the structure, function, and regulatory mechanisms of the T3SSs in
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each of the organisms that express them. Like many of the pathogens expressing T3SSs,
Shigella virulence is absolutely reliant on a fully functional T3SS capable of appropriately
timing the injection of effector proteins into the cytoplasm of host cells [6–9]. A great deal
of work has been done to understand the transcriptional regulation of T3SS gene expression in which invasion genes located on the 220kb invasion plasmid are controlled by the
transcriptional regulator VirB, whose expression is in turn controlled by the temperaturedependent expression of the master regulator VirF [30–32]. As a human enteric pathogen,
initiating transcription of VirB at temperatures exceeding 30 ◦ C prevents the unnecessary
and wasteful expression of Shigella T3SS genes while outside of the host organism. While
Shigella clearly rely on transcriptional control to regulate virulence and arm its T3SS arsenal
once ingested by the host, specific targeting of the colonic epithelium and other carefully
orchestrated events such as vacuolar escape and induced apoptosis of macrophages make
it highly unlikely that these early transcriptional regulation events alone can support the
strict timing required during Shigella infection.
Most likely, the well-described transcriptional regulation of T3SS genes is complemented by additional, faster acting, regulatory processes sensitive to specific environmental
cues. For example, from their positions at the distal tip of the injectisome, the proteins IpaD
and IpaB each trigger critical steps in T3SS injectisome tip maturation following exposure to
the bile salt deoxycholate and host membrane components, respectively, preparing Shigella
for invasion of the colonic epithelium [25,26,46–49]. Furthermore, we have recently solved
a series of high-resolution structures of the Shigella T3SS protein, Spa47, and have provided
enzymatic characterization identifying it is an oligomerization-activated ATPase essential
for T3SS function and Shigella virulence [35,36,40]. Its role in supporting both proper injectisome formation and protein effector secretion makes Spa47 an attractive target for native
and therapeutic regulation/inhibition of T3SS activity. In fact, a recent study confirmed this
when the T3SS protein MxiN was identified as a Spa47 chaperone, differentially regulating
ATPase activity dependent on the oligomeric state of Spa47, suggesting that MxiN is a
critical component in the regulatory pathway controlling Shigella T3SS activity [16]. Followup works targeting Spa47’s role in the Shigella T3SS identified several non-competitive
small molecule Spa47 inhibitors that not only inhibit ATPase activity in vitro, but efficiently
reduce in vivo T3SS protein secretion by as much as 95%, confirming the potential for Spa47
as a regulatory target and providing a strong foundation for the development of much
needed non-antibiotic therapeutics against Shigella infections [50,51].
Standish and coworkers recently completed a tyrosine phosphoproteomics study
for Shigella flexneri, uncovering 905 unique tyrosine posttranslational phosphorylation
sites that spanned ≥573 proteins [34]. Twenty-one of the identified proteins were T3SS
proteins, providing the first direct evidence of Shigella T3SS protein posttranslational
phosphorylation. While it is likely that these modifications play important regulatory
roles in many of the identified protein targets, this specifically opened a new avenue of
opportunity for exploring the role of posttranslational modification in regulating Shigella
virulence through T3SS activity. In line with this reasoning, three of the T3SS proteins found
to contain posttranslational phosphotyrosine modifications include MxiN, VirB, and Spa47.
MxiN has been shown to interact with Spa47 and differentially regulate ATPase activity
of monomeric and oligomeric forms of the enzyme [16] and plaquing and qualitative
secretion assays of phosphomimetic mutants of the latter two [34] support the idea that
phosphorylation of these proteins may reduce Shigella virulence phenotype. Interestingly,
this study showed that knocking out Wzc, the only known tyrosine kinase in Shigella, had
no effect on the tested phenotype, suggesting that at least one yet-to-be identified tyrosine
kinase/phosphatase pair is responsible for controlling the phosphorylation state of Shigella
T3SS proteins, reminding us of just how little is currently known about T3SS regulation.
In this study, we leveraged the ability to express and purify enzymatically active Spa47
to examine the effects of the identified phosphorylation events on Spa47 ATPase activity
and its role in Shigella T3SS function and pathogen virulence. Several mutations were
made to each of the tyrosine residues identified previously as targets for phosphorylation
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(Y274 and Y398) and all resulted in significant decreases in ATPase activity by Spa47,
with activity essentially abolished in the phosphomimetic glutamate substitution mutants,
clearly demonstrating that both tyrosine residues are essential for appropriate activity
in vitro. Although the specific mechanism for this disruption is not entirely clear, similar
mutations made to interfacial amino acids in Spa47 have been linked to disruption of a
complex intermolecular hydrogen bonding network that ultimately affects the geometry of
critical residues within the interfacial active site of the complex [37]. While distant from the
active site, both Y274 and Y398 are also located at the interface of Spa47 protomers in the
context of the activated Spa47 oligomer and perhaps they too are involved in intermolecular
interaction that support an ATPase competent structure. Work is currently underway to
solve X-ray crystal structures of the mutants engineered in this study and the findings will
likely shed additional light on the specific structural role(s) of these important tyrosines.
Extensive in vivo phenotype studies including induced T3SS translocator secretion,
eukaryotic host cell invasion, and erythrocyte hemolysis assays were additionally performed in this study to assess the effect of the engineered mutations of tyrosines 274 and
398 on T3SS function and Shigella virulence. While each assay assesses specific aspects
of T3SS function and different steps in the infection mechanism, each of these functions
is absolutely reliant on proper Spa47 ATPase activity, providing an important readout
with respect to the potential effects of phosphorylation at the identified tyrosine targets.
Somewhat surprisingly, we found that despite clear reductions in ATPase activity of the
isolated Spa47Y398 mutants, none of the Shigella strains expressing mutations to tyrosine
398 exhibited reduced T3SS function or Shigella virulence (in fact all resulted in a modestly
enhanced hemolysis phenotype compared to wild-type), as perhaps the deleterious effects
of the mutation were overcome by favorable protein interactions in the context of the
assembled T3SS injectisome, making it likely that phosphorylation observed at Y398 in
the phosphotyrosine proteomics study [34] is the result of an enigmatic and promiscuous
kinase and not one that drives regulation of T3SS activity. The Shigella strains expressing
the engineered Spa47Y274 mutants, however, resulted in a consistent pattern of reducing
virulence phenotype as the mutation changed from phenylalanine to alanine to glutamate,
as would be expected if phosphorylation of Y274 reduced T3SS function through a reduction in Spa47 activity. Furthermore, it is tempting to speculate that the highly conserved
placement of tyrosine in the position equivalent to Spa47Y274 in homologous T3SS ATPases
is the result of a conserved regulatory pathway that takes advantage of this virulence modulation in related pathogens. Little is currently known, however, regarding the impact/use
of posttranslational modifications in controlling type three secretion system ATPase activity
and it is hopeful that these studies will provide the momentum necessary for follow-up
work that not only uncovers the molecular details of the observed effects in Shigella, but
that also extend these studies to explore the potential for a conserved pathway in other
T3SS-expressing pathogens.
In conclusion, the data presented here provide the first enzymatic study of a PTM on a
T3SS ATPase and correlate these findings to Shigella T3SS function and virulence. Taken
together, the presented in vitro enzyme characterization and in vivo Shigella virulence
phenotype characterizations strongly support the hypothesis that the posttranslational
phosphorylation of Spa47Y274 reduces Spa47 activity, T3SS function, and Shigella virulence.
The next critical steps in continuing this work include identifying the specific kinase(s) and
phosphatase(s) involved in the Spa47 phosphorylation pathway and ultimately describing
the stimuli and mechanisms that regulate their action. Uncovering these pathways not only
provides critical information that helps to close the significant gap in our understanding of
how T3SSs are regulated, but also identifies a potentially potent target for the development
of non-antibiotic therapeutics against infections by Shigella and related bacterial pathogens.
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4. Materials and Methods
4.1. Materials
The Spa47 null Shigella flexneri strain was generated and validated previously by
the Allaoui lab [52]. Rabbit polyclonal anti-IpaC antibodies and the pWPsf4 expression
plasmid were generous gifts from Wendy Picking at the University of Kansas and have been
validated previously [35,42]. E. coli NovaBlue and Tuner (DE3) cells and ligation mix were
purchased from Novagen (Madison, WI, USA). The pTYB21 plasmid, PCR buffer, Phusion
polymerase, chitin affinity resin, and restriction enzymes were from New England Biolabs
(Ipswich, MA, USA). The synthetic Spa47 gene and PCR primers were from Integrated DNA
Technologies (Coralville, IA, USA). All antibiotics, IPTG, and DTT were purchased from
Gold Biotechnology (St. Louis, MO, USA). The anion exchange and size exclusion columns
were from Cytiva (Marlborough, MA, USA). ATP was from Sigma–Aldrich (St. Louis, MO,
USA) and radioactive α-32 P-ATP was from Perkin Elmer (Boston, MA, USA). All other
solutions and chemicals were of reagent grade.
4.2. Cloning
The wild-type sequence gene for Spa47 was purchased from Integrated DNA Technologies and ligated into the commercial expression plasmid pTYB21, which encodes an
N-terminal chitin binding domain (CBD) and cleavable intein linker. It was then heat shock
transformed into E. coli NovaBlue cells, and resulting colonies were screened for spa47 and
sequence-verified by Genewiz (South Plainfield, NJ, USA). The wild-type Spa47 gene was
also cloned into the high copy number, pUC18-based pWPsf4 plasmid [42] for constitutive
expression in Shigella. Shigella strains expressing wild-type and mutant Spa47 from the
pWPsf4 plasmid were generated by electroporation of a S. flexneri spa47 knockout strain.
The Spa47 point mutants in this study were made in both pTYB21 and pWPsf4 backbones,
used inverse PCR, and were transformed into E. coli and S. flexneri, respectively, following
sequence validation.
4.3. Protein Expression and Purification
E. coli Tuner (DE3) cells containing the Spa47 genes in pTYB21 were grown to saturation in LB Broth (Miller) supplemented with 0.1 mg/mL ampicillin. A small amount of
the saturated culture was used to inoculate one-liter cultures in Terrific Broth media again
supplemented with 0.1 mg/mL ampicillin. The cultures were grown in a shaker at 37 ◦ C
and 200 RPM to an OD600 of 0.8 prior to cooling to 17 ◦ C and induction with 1 mM IPTG
for 20 h at 17 ◦ C and 200 RPM. All subsequent protein purification steps were performed at
4 ◦ C. Following expression, cells were pelleted by centrifugation, resuspended in chitin
binding buffer (20 mM Tris, 500 mM NaCl, 0.2 mM AEBSF. pH 7.9), and lysed by sonication.
The sonicated product was centrifuged and the supernatant containing soluble protein
run over a chitin affinity column. The chitin resin was then rinsed generously with chitin
binding buffer followed by overnight incubation in intein cleavage buffer (20 mM Tris,
500 mM NaCl, 50 mM DTT, pH 7.9) to cleave Spa47 from the chitin binding domain (CBD).
Several protein elutions were collected and assessed via SDS-PAGE. The elutions were
combined and adjusted to a final concentration of 20 mM Tris, 100 mM NaCl, 5 mM DTT,
pH 7.9, and further purified via negative selection using a Q Sepharose FF anion exchange
column. The purified protein was concentrated using centrifugal filter units with 30-kDa
molecular weight cut offs and further purified/characterized using a Superdex 10/300 size
exclusion column equilibrated with 20 mM Tris, 100 mM NaCl, 5 mM DTT, pH 7.9. Spa47
concentrations were determined using SDS-PAGE in-gel densitometry with bovine serum
albumin as a standard, as validated previously [35]. All Spa47 concentrations are reported
in monomer concentration units for consistency and clarity.
4.4. ATP Hydrolysis Activity Assays
A multiple time point activity assay was used to quantify Spa47 activity (ATP hydrolysis rates) from collected size exclusion chromatography (SEC) fractions of each of the Spa47
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variants. The reactions were initiated by combining Spa47 protein with a prepared ATP
solution resulting in a final concentration of 0.5 µM Spa47 (monomer or oligomer), 1 mM
ATP, 10 mM MgCl2 , and 0.5 µCi (∼300 nM) α-32 P-ATP. Reaction aliquots were removed
and rapidly quenched with 0.25 M EDTA 60, 120, 300, 900, and 1800 s following reaction initiation. Cleaved α-32 P-ADP and uncleaved α-32 P-ATP were separated for each time point
via TLC and quantified following exposure to a phosphor imaging screen and detection
using a Storm 860 molecular imager [53].
4.5. Far-UV Circular Dichroism (CD)
Far-UV CD spectra and thermal stability profiles were collected for SEC-isolated
monomeric and oligomeric fractions of each Spa47 mutant. CD data were obtained using a
JASCO model J-1500 spectropolarimeter with a Peltier temperature controller (Jasco, Easton,
MD, USA). Samples were placed in 0.1 cm path length quartz cuvettes and equilibrated to
10 ◦ C prior to collecting spectral data from 200 to 260 nm. Collection parameters included
a 50 nm min−1 scan rate, 1 s data integration, and 0.5 nm spectral resolution. Thermal
stability profiles were obtained by collecting CD data at 222 nm as the sample temperature
was increased from 10 ◦ C to 90 ◦ C at 0.3 ◦ C/min. Protein secondary structure thermal
transition temperatures (Tm) were obtained by determining the minimum of the first
derivative curve of the sigmoidal function fit to the variable temperature CD data. All CD
analyses were performed at 0.5 mg/mL protein concentration and values presented as the
mean ± S.D. of three independent measurements. All CD signals were converted to mean
residue molar ellipticity.
4.6. Shigella-Induced Erythrocyte Hemolysis
The impact of the Spa47 tyrosine mutations on type three secretion system-mediated
red blood cell hemolysis was investigated using a previously published protocol [54].
Briefly, Shigella strains expressing the engineered Spa47 tyrosine mutants as well as control
strains including a spa47 knockout, a spa47 knockout vector control containing the pWPsf4
expression vector, but no gene for Spa47, and a spa47 knockout strain complemented
with wild-type spa47 were grown in tryptic soy broth containing appropriate antibiotics.
The cultures were grown to an OD600 of 1.0 prior to pelleting via centrifugation. The
bacteria were resuspended in PBS and each Shigella suspension was introduced to ∼5 × 108
red blood cells in a 96-well microtiter plate. Centrifugation at 2300× g initiated contact
between the red blood cells and the Shigella prior to a 1 h incubation at 37 ◦ C to allow T3SS
translocon insertion into the blood cell membranes. The red blood cells and Shigella were
then resuspended following the addition of 100 µL of cold PBS per well. The resuspended
mix was again centrifuged to pellet the bacteria and erythrocytes. The soluble hemoglobin
that was released as a result of membrane disruption by the Shigella was quantified by
measuring absorbance at 545 nm and compared with the levels resulting from S. flexneri
expressing wild-type Spa47 and a PBS negative control solution lacking bacteria.
4.7. Bacterial Invasion of Epithelial Cells
S. flexneri invasion of cultured HeLa cells was monitored by a gentamicin protection
assay using a modified version of a previously described protocol [55]. Briefly, HeLa
cells were grown overnight in sterile 24-well plates containing DMEM supplemented
with streptomycin, penicillin, and 10% fetal calf serum in an incubator maintaining and
environment of 37 ◦ C, 100% relative humidity, and 5% CO2 . The engineered Shigella strains
used throughout this study were grown in tryptic soy broth media at 37 ◦ C and 200 RPM
to an OD600 of 0.4 prior to introduction of equivalent bacterial loads to the cultured HeLa
cells. Centrifuging the plates at 1000× g synchronized contact between the HeLa cells and
Shigella and initiated invasion that was further supported by incubation at 37 ◦ C for 30 min.
The HeLa cells were then rinsed to remove most of the extracellular bacteria. Shigella that
had not successfully invaded the HeLa cells were then killed by treatment with 50 µg/mL
gentamicin. Bacteria that had invaded were visualized by lysing the host cells with 1%
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agarose in water and overlaying with a 2× LB agar solution. Overnight incubation at
37 ◦ C resulted in colony formation from the individual Shigella released from the HeLa
cells’ cytoplasm. Enumerating the resulting colonies provides a quantitative measure of
the ability of the S. flexneri strains to invade host cells and initiate infection.
4.8. Quantitation of S. flexneri T3SS Translocator Secretion
Congo Red is a small diazo dye that effectively initiates secretion of T3SS translocator
proteins from Shigella by triggering the natural response resulting from interaction with
host cell membrane components [56]. Thus, treatment with Congo Red has proven to
be a valuable tool capable of dissecting the impact of individual protein mutations, such
as the Spa47 tyrosine phosphomimetics used in this study, on Shigella T3SS activation
and protein secretion. The Congo Red secretion protocol has been described in detail
elsewhere [57]. The Shigella strains described previously in this study were grown to an
OD600 of 1.0 at 37 ◦ C in tryptic soy broth containing appropriate antibiotics to maintain
the transformed protein expression plasmid. The cultures were then rapidly chilled on
ice to temporarily slow translocator protein expression and secretion. The bacteria were
isolated by centrifuging the cultures and rinsing the resulting cell pellets to ensure removal
of any proteins that had been secreted up to this point. The bacteria were then incubated
at 37 ◦ C for 15 min in sodium phosphate buffer containing 0.28 mg/mL Congo Red to
activate the T3SS and initiate effector secretion. The Shigella were again cooled on ice to
limit further secretion and were centrifuged at 13,000× g for 15 min to separate them from
the supernatant which contained secreted T3SS effector proteins. The isolated proteins that
were then separated by SDS-PAGE, transferred to PVDF membranes by Western blot, and
visualized using anti-IpaC rabbit polyclonal antibodies and an Alexa 647 goat anti-rabbit
secondary antibody. The rabbit polyclonal anti-IpaC antibodies have been previously
validated for specific detection of IpaC in a similar Congo Red secretion assay [35]. Secreted
IpaC levels were detected and compared using a Bio-Rad ChemiDoc imaging system and
the associated Image Lab analysis software. Antibodies against the cytoplasmic glycolytic
enzyme glyceraldehyde 3-phosphate dehydrogenase (GAPDH) served as a lysis control,
verifying that IpaC detected in the supernatant resulted from T3SS activity.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/pathogens11020202/s1, Figure S1: Circular Dichroism characterization of phosphomimetic
Spa47 mutants.
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